Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Medical Oncology
Financial toxicity
Questions discussed in this category
What are your top takeaways from SGO 2022?
10 Answers available
What are your top takeaways from SGO 2023?
7 Answers available
12373
15871
Papers discussed in this category
N Engl J Med, 2021 Sep 18
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
N Engl J Med, 2022 Jan 19
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.
N Engl J Med, 2023 Mar 27
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.
N Engl J Med, 2023 Mar 27
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Related Topics in Medical Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers
